Market revenue in 2021 | USD 67.0 million |
Market revenue in 2030 | USD 148.1 million |
Growth rate | 9.2% (CAGR from 2021 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Clinical |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preclinical, Clinical |
Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 67.01% in 2021. Horizon Databook has segmented the UK large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Rapidly rising pharmaceutical and biopharmaceutical R&D expenditure in the country will drive the market for large molecule bioanalytical testing. For instance, around 24,000 citizens of the UK are employed for pharmaceutical R&D.
Furthermore, according to office for national statistics, current per capita healthcare expenditure of the UK was around USD 4,504. This high healthcare expenditure will also provide suitable space for large molecule bioanalytical testing market to thrive.
Growing geriatric population in the country will also drive the need for better healthcare and drive investments on large molecule bioanalytical testing. For instance, in 2016, around 11.8 million citizens in the UK were 65 years or above, which is 18% of the overall population.
Horizon Databook provides a detailed overview of country-level data and insights on the UK large molecule bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into UK large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account